Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017.
Tiffany A SuraghPaige LewisJorge AranaAdamma Mba-JonasRongxia LiBrock StewartTom T ShimabukuroMaria CanoPublished in: British journal of clinical pharmacology (2018)
We did not identify any new or unexpected safety concerns in our review of 2vHPV reports to VAERS.
Keyphrases